News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
95 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32397)
Month
January (2936)
February (2969)
March (2710)
April (2907)
May (3626)
June (2409)
July (2088)
August (2589)
September (2381)
October (3064)
November (3190)
December (1528)
Day
1 (53)
2 (189)
3 (164)
4 (141)
5 (84)
8 (188)
9 (95)
10 (176)
11 (109)
12 (112)
15 (98)
16 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
Press Releases
Cell and Gene Therapy Quality Control and Analytics Market Accelerates as AI, Advanced Testing, and Global Partnerships Drive Next-Gen Therapeutics
December 9, 2025
·
1 min read
Press Releases
Cancer Biomarkers Market Size Worth USD 43.05 Bn by 2034 Powered by Expanding Use of Liquid Biopsy Technologies
December 9, 2025
·
1 min read
Press Releases
CellCentric Presents Positive Phase 2 Dose Optimization Data for Inobrodib in Multiple Myeloma at ASH Annual Meeting
- Inobrodib in combination with pomalidomide + dexamethasone (InoPd) demonstrates strong clinical efficacy and a tolerable safety profile in heavily pretreated relapsed/refractory multiple myeloma (RRMM) patients - - Observed response rates of 60-75% with inobrodib 20 mg and 30 mg cohorts result in clinical efficacy at least two-fold higher than previously published real-world data for pom-refractory, bispecific or anti-BCMA exposed patients -
December 9, 2025
·
4 min read
Press Releases
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
December 9, 2025
·
6 min read
Press Releases
BioLumic Expands Light-Activated Seed Trait Platform to South America
December 9, 2025
·
1 min read
Previous
10 of 10
